Retraction of: Scientific Reports https://doi.org/10.1038/s41598-017-06353-2, published online 24 July 2017
The Editors have retracted this Article.
After publication of this Article it was brought to the Editors’ attention that some of the images appear to overlap with those in other published articles, where the data is partially attributed to different samples. Specifically:
-
In Fig. 2C (right panel) and D (left panel) appear to partially overlap between the HOS-1 and HOS-29 groups;
-
In Fig. 2D and 7A the image appears to be rotated;
-
In Fig. 3C the “hFOB” group seems to overlap with Fig. 6D “non-infected” group;
-
In Fig. 3E and 7B there appears to be a partial overlap between the “HOS” and “non-infected” (upper panel) groups;
-
In Fig. 7A and B there appears to be a partial overlap between the “EFEMP1 shRNA” condition (top panel) and “HOS-29 neg control” (top panel) group;
-
In Fig. 7B there appears to be a partial overlap between the “non-infected” (top panel) and “HOS-29 neg control” (top panel) groups;
-
In Fig. 4E and 5A appear to partially overlap between the “HOS-1” conditions;
-
In Fig. 6C the “HOS-1 neg control” group appears to partially overlap with Fig. 2C “HEC-1A” group in1;
-
In Fig. 9A the “Slug” immunoblot appear to be partially overlapping with Fig. 10A “N-Cadherin” blot and 11A “E-Cadherin” blot in1;
-
In Fig. 10B the “GSK3-beta pS9” blot seems to be overlapping with Fig. 4C “Cyclin-B1” blot in2.
The Editors reached out to the Authors to request raw data. The Authors provided the data which did not address the concerns. The Editors therefore no longer have confidence in the results presented in this Article.
Songgang Wang, Dong Zhang, Shasha Han, Peng Gao, Changying Liu, and Jianmin Li did not respond to the correspondence about this retraction. Xin Pan did not state explicitly whether they agree to or disagree with this retraction.
References
Wang, T. et al. Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway. Oncotarget 8, 12. https://doi.org/10.18632/oncotarget.15086 (2017).
Yin, X. et al. EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway. Oncotarget 7, 30. https://doi.org/10.18632/oncotarget.10296 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, S., Zhang, D., Han, S. et al. Retraction Note: Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway. Sci Rep 13, 11641 (2023). https://doi.org/10.1038/s41598-023-38918-9
Published:
DOI: https://doi.org/10.1038/s41598-023-38918-9
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
